These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 17509027)

  • 1. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment.
    Drossman D; Morris CB; Hu Y; Toner BB; Diamant N; Whitehead WE; Dalton CB; Leserman J; Patrick DL; Bangdiwala SI
    Am J Gastroenterol; 2007 Jul; 102(7):1442-53. PubMed ID: 17509027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire.
    Drossman DA; Patrick DL; Whitehead WE; Toner BB; Diamant NE; Hu Y; Jia H; Bangdiwala SI
    Am J Gastroenterol; 2000 Apr; 95(4):999-1007. PubMed ID: 10763950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What determines severity among patients with painful functional bowel disorders?
    Drossman DA; Whitehead WE; Toner BB; Diamant N; Hu YJ; Bangdiwala SI; Jia H
    Am J Gastroenterol; 2000 Apr; 95(4):974-80. PubMed ID: 10763947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical response to tricyclic antidepressants in functional bowel disorders is not related to dosage.
    Halpert A; Dalton CB; Diamant NE; Toner BB; Hu Y; Morris CB; Bangdiwala SI; Whitehead WE; Drossman DA
    Am J Gastroenterol; 2005 Mar; 100(3):664-71. PubMed ID: 15743366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life impact as outcome in burns patients.
    Novelli B; Melandri D; Bertolotti G; Vidotto G
    G Ital Med Lav Ergon; 2009; 31(1 Suppl A):A58-63. PubMed ID: 19621540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.
    Spiegel BM; Gralnek IM; Bolus R; Chang L; Dulai GS; Mayer EA; Naliboff B
    Arch Intern Med; 2004 Sep; 164(16):1773-80. PubMed ID: 15364671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
    Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
    Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combination of medical treatment plus multicomponent behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome.
    Heymann-Mönnikes I; Arnold R; Florin I; Herda C; Melfsen S; Mönnikes H
    Am J Gastroenterol; 2000 Apr; 95(4):981-94. PubMed ID: 10763948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
    Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M
    Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: epidemiology and quality of life in functional gastrointestinal disorders.
    Chang L
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():31-9. PubMed ID: 15521853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia.
    Sperber AD; Carmel S; Atzmon Y; Weisberg I; Shalit Y; Neumann L; Fich A; Friger M; Buskila D
    Am J Gastroenterol; 2000 Apr; 95(4):995-8. PubMed ID: 10763949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
    Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
    J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome.
    Watson ME; Lacey L; Kong S; Northcutt AR; McSorley D; Hahn B; Mangel AW
    Am J Gastroenterol; 2001 Feb; 96(2):455-9. PubMed ID: 11232690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative analysis of efficiency of the estimation of quality of life in patients with irritable bowel syndrome using questionnaires IBS-QOL and index BEST].
    Pilipenko VI; Isakov VA
    Eksp Klin Gastroenterol; 2008; (6):4-8. PubMed ID: 19334419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER.
    Reed C; Monz BU; Perahia DG; Gandhi P; Bauer M; Dantchev N; Demyttenaere K; Garcia-Cebrian A; Grassi L; Quail D; Tylee A; Montejo AL
    J Affect Disord; 2009 Mar; 113(3):296-302. PubMed ID: 18603303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abdominal pain impacts quality of life in women with irritable bowel syndrome.
    Cain KC; Headstrom P; Jarrett ME; Motzer SA; Park H; Burr RL; Surawicz CM; Heitkemper MM
    Am J Gastroenterol; 2006 Jan; 101(1):124-32. PubMed ID: 16405544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications.
    Sperber AD; Atzmon Y; Neumann L; Weisberg I; Shalit Y; Abu-Shakrah M; Fich A; Buskila D
    Am J Gastroenterol; 1999 Dec; 94(12):3541-6. PubMed ID: 10606316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of quality of life in irritable bowel syndrome.
    Rey E; García-Alonso MO; Moreno-Ortega M; Alvarez-Sanchez A; Diaz-Rubio M
    J Clin Gastroenterol; 2008 Oct; 42(9):1003-9. PubMed ID: 18719505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-related quality of life in subjects with functional bowel disorders in Germany.
    Icks A; Haastert B; Enck P; Rathmann W; Giani G
    Z Gastroenterol; 2002 Oct; 40(10):863-7. PubMed ID: 12436352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life measures in irritable bowel syndrome.
    Wong RK; Drossman DA
    Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):277-84. PubMed ID: 20528115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.